These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [New antifungal agents in the treatment of superficial dermatomycoses]. Degreef H Ann Dermatol Venereol; 1993; 120(1):21-31. PubMed ID: 8393313 [TBL] [Abstract][Full Text] [Related]
3. The triazole antifungal agents: a review of itraconazole and fluconazole. Bailey EM; Krakovsky DJ; Rybak MJ Pharmacotherapy; 1990; 10(2):146-53. PubMed ID: 2161523 [TBL] [Abstract][Full Text] [Related]
4. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens. Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753 [TBL] [Abstract][Full Text] [Related]
8. Current trends in onychomycosis therapy: a literature review. Hecker D Mt Sinai J Med; 1997 Nov; 64(6):399-405. PubMed ID: 9364835 [TBL] [Abstract][Full Text] [Related]
9. The use of systemic antimycotics in dermatotherapy. Niewerth M; Korting HC Eur J Dermatol; 2000 Mar; 10(2):155-60. PubMed ID: 10694319 [TBL] [Abstract][Full Text] [Related]
10. Itraconazole in dermatophyte infections: clinical experience in Italy. Difonzo EM; Panconesi E; Cilli P Br J Clin Pract Suppl; 1990 Sep; 71():114-7. PubMed ID: 1965414 [TBL] [Abstract][Full Text] [Related]
11. Drugs for treatment of fungal infections. Med Lett Drugs Ther; 1992 Feb; 34(864):14-6. PubMed ID: 1310518 [No Abstract] [Full Text] [Related]
12. The significance of itraconazole for treatment of fungal infections of skin, nails and mucous membranes. Korting HC; Schöllmann C J Dtsch Dermatol Ges; 2009 Jan; 7(1):11-9, 11-20. PubMed ID: 18479501 [TBL] [Abstract][Full Text] [Related]
13. Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. Restrepo A; Robledo J; Gómez I; Tabares AM; Gutiérrez R Arch Dermatol; 1986 Apr; 122(4):413-7. PubMed ID: 3006602 [TBL] [Abstract][Full Text] [Related]
14. Terbinafine: broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases. Pérez A Mycoses; 1999; 42 Suppl 2():111-4. PubMed ID: 10865916 [TBL] [Abstract][Full Text] [Related]
15. Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy. Van Cutsem J Br J Clin Pract Suppl; 1990 Sep; 71():32-40. PubMed ID: 1965417 [TBL] [Abstract][Full Text] [Related]
16. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium. Sarifakioglu E; Seçkin D; Demirbilek M; Can F Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532 [TBL] [Abstract][Full Text] [Related]
17. Antifungal agents. Part II. The azoles. Terrell CL Mayo Clin Proc; 1999 Jan; 74(1):78-100. PubMed ID: 9987539 [TBL] [Abstract][Full Text] [Related]
18. Recent advances in the treatment of systemic fungal infections. Walsh TJ Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615 [TBL] [Abstract][Full Text] [Related]
19. Treatments for common superficial fungal infections. Aly R; Forney R; Bayles C Dermatol Nurs; 2001 Apr; 13(2):91-4, 98-9; quiz 100-1. PubMed ID: 11917313 [TBL] [Abstract][Full Text] [Related]
20. Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell-mediated immunity. Schmid-Wendtner MH; Korting HC J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1013-8. PubMed ID: 17714119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]